Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis is a research paper published in Brain Communications (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 216596
Identifying and verifying non-coding genetic causes of amyotrophic lateral sclerosis
National Institutes of Health
Grant: 5P30DK116074-04
Stanford Diabetes Research Center
National Institutes of Health
Grant: 5R01HL101388-04
DNA Variants and AAA Disease
National Institutes of Health
Grant: 1S10OD025212-01
Ultra high throughput sequencer for sustaining and enhancing multi-scale genomic studies
National Institutes of Health
Grant: 5R01HL122939-02
MicroRNA Regulation of Nicotine Accelerated AAAs
National Institutes of Health
Grant: 5UM1HG009442-04
PRODUCTION CENTER FOR MAPPING REGULATORY REGIONS OF THE HUMAN GENOME
National Institutes of Health
Grant: 5P50HL083800-04
AAA Disease: Mechanism, Stratification and Treatment
Motor Neurone Disease Association
Grant: ALLEN/OCT15/956-799
Motor Neurone Disease Association
Grant: TURNER/OCT15/972-797
Fields of Study
Keywords
Sustainable Development Goals